[144] Cadrenal Therapeutics, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for proposed sale of securities under Rule 144. The filing shows an intended sale of 1,193 common shares through Merrill Lynch on 08/28/2025 with an aggregate market value of $16,540.64. The shares were acquired as founders shares on 01/25/2022 from the company. The filing reports 2,046,854 shares outstanding for the class listed. Separately, the document discloses a recent sale by Quang Pham of 3,836 common shares on 08/27/2025 that generated $53,455.56 in gross proceeds. The issuer name and CIK are not provided in the visible content, and the filer contact details are blank.

Positive

• Required sale details provided: share counts, dates, broker, and aggregate values are included for the proposed sale and recent sale
• Acquisition history disclosed: the filing states the shares were founders shares acquired 01/25/2022, clarifying origin

Negative

• Issuer and filer identifiers missing: the issuer name and CIK are not provided in the visible content, limiting verification
• Contact information blank: submission contact details and filer CIK/CCC are not present, reducing traceability

Insights

Securities Compliance Analyst

TL;DR: Routine insider resale notice showing small founder and recent sale activity; missing issuer identifiers limit immediate tracking.

The filing documents a proposed resale of 1,193 common shares acquired as founders shares on 01/25/2022, to be executed via Merrill Lynch on 08/28/2025 for $16,540.64 aggregate market value. It also discloses a prior sale by Quang Pham of 3,836 shares on 08/27/2025 for $53,455.56. From a compliance perspective, the form records necessary sale details and acquisition history consistent with Rule 144 reporting. However, the absence of the issuer name and CIK in the provided content reduces the ability to cross-check insider status, holding limits, or aggregation with other filings.

Corporate Governance Specialist

TL;DR: Disclosure appears routine and non-material given amounts; incomplete issuer identification is a practical issue for stakeholders.

The amounts disclosed—1,193 shares (~$16.5k) proposed and a recent 3,836-share sale (~$53.5k)—are modest relative to typical market caps and do not in themselves indicate material corporate change. The acquisition entry shows these were founders shares dated 01/25/2022, which clarifies origin. For governance monitoring, the missing issuer name and filer identifiers are notable gaps that should be resolved to confirm insider relationship and any blackout or trading-plan context.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 824 A1A North Suite 200 Ponte Vedra Beach FL 32082	1193	16540.64	2046854	08/28/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/25/2022	Founders Shares	Company			1193	01/25/2022	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Quang Pham 830 A1A North Suite 196 Ponte Vedra Beach FL 32082	Common	08/27/2025	3836	53455.56

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for CVKD disclose about the proposed sale?

The filing shows a proposed sale of 1,193 common shares via Merrill Lynch on 08/28/2025 with an aggregate market value of $16,540.64.

When and how were the shares being sold acquired?

The 1,193 shares were acquired as founders shares on 01/25/2022 from the company.

Did the filer sell any shares recently prior to this proposed sale?

Yes. The document reports Quang Pham sold 3,836 common shares on 08/27/2025 for $53,455.56 in gross proceeds.

Which broker is handling the proposed sale?

The broker listed for the proposed sale is Merrill Lynch with an address in Ponte Vedra Beach, FL.

Are there any missing details that affect how investors can verify this filing?

Yes. The visible content does not include the issuer name, CIK, or complete filer contact information, which limits external verification.